Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis
Mild cognitive impairment (MCI) is common in patients with hypertension. Prevalence estimates of MCI in hypertensive patients are needed to guide both public health and clinical decision making. A literature search was conducted in four databases, including PubMed, Embase, Cochrane Library, and Web...
Gespeichert in:
| Veröffentlicht in: | Hypertension research 2021-10, Vol.44 (10), p.1251-1260 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1260 |
|---|---|
| container_issue | 10 |
| container_start_page | 1251 |
| container_title | Hypertension research |
| container_volume | 44 |
| creator | Qin, Jiawei He, Zexiang Wu, Lijian Wang, Wanting Lin, Qiuxiang Lin, Yiheng Zheng, Liling |
| description | Mild cognitive impairment (MCI) is common in patients with hypertension. Prevalence estimates of MCI in hypertensive patients are needed to guide both public health and clinical decision making. A literature search was conducted in four databases, including PubMed, Embase, Cochrane Library, and Web of Science, from their inception to February 2021. The methodological quality assessment used the risk of bias tool. The pooled prevalence of MCI in hypertensive patients was determined by a random-effects model. Heterogeneity was explored using sensitivity analysis, subgroup analysis, and random effects meta-regression. Of 2314 references, 11 studies (47,179 participants) were included in the meta-analysis. The overall pooled prevalence of MCI in patients with hypertension was 30% (95% CI, 25-35), with significant heterogeneity present (I
= 99.3%, p |
| doi_str_mv | 10.1038/s41440-021-00704-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2553819671</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2553819671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c355t-781b7f3c1d1654278c8b7d59788b502e2072e32bbc9fe564d25db30bd741c8463</originalsourceid><addsrcrecordid>eNpdkU9P3DAUxK2qqCzbfgEOyBIXLi7-Gzu9VQhKJSQ40LPlOC9do8RJbS9ovz3eLuXQ05vDb0ZPMwidMvqVUWEus2RSUkI5I5RqKon4gFZMSEMkZ_IjWtGWNaRtRHOMTnJ-opQb1bJP6FjIqoQ2KzQ-JHh2I0QPeB7wFMYe-_l3DCU8Aw7T4kKaIBYcIl5cCVVm_BLKBm92C6QCMYc5fsMO510uMFXE4xoZ4AW72OMJiiMuunGXQ_6MjgY3Zvjydtfo183149Utubv_8fPq-x3xQqlCtGGdHoRnPWuU5Np40-letdqYTlEOnGoOgnedbwdQjey56jtBu15L5o1sxBpdHHKXNP_ZQi52CtnDOLoI8zZbrpQwrG00q-j5f-jTvE313z2lTS2Q0j3FD5RPc84JBrukMLm0s4za_Rb2sIWtW9i_W1hRTWdv0dtugv7d8q988Qp6qoUG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2578916001</pqid></control><display><type>article</type><title>Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Qin, Jiawei ; He, Zexiang ; Wu, Lijian ; Wang, Wanting ; Lin, Qiuxiang ; Lin, Yiheng ; Zheng, Liling</creator><creatorcontrib>Qin, Jiawei ; He, Zexiang ; Wu, Lijian ; Wang, Wanting ; Lin, Qiuxiang ; Lin, Yiheng ; Zheng, Liling</creatorcontrib><description>Mild cognitive impairment (MCI) is common in patients with hypertension. Prevalence estimates of MCI in hypertensive patients are needed to guide both public health and clinical decision making. A literature search was conducted in four databases, including PubMed, Embase, Cochrane Library, and Web of Science, from their inception to February 2021. The methodological quality assessment used the risk of bias tool. The pooled prevalence of MCI in hypertensive patients was determined by a random-effects model. Heterogeneity was explored using sensitivity analysis, subgroup analysis, and random effects meta-regression. Of 2314 references, 11 studies (47,179 participants) were included in the meta-analysis. The overall pooled prevalence of MCI in patients with hypertension was 30% (95% CI, 25-35), with significant heterogeneity present (I
= 99.3%, p < 0.001). In subgroup analyses, Asian and European samples had a prevalence of 26% (95% CI, 20-31) and 40% (95% CI, 14-66), respectively; cross-sectional and cohort studies had a prevalence of 28% (95% CI, 24-32) and 38% (95% CI, -5-81); age older than 60 years had a prevalence of 28% (95% CI, 23-33); community-based and clinic-based samples had a prevalence of 17% (95% CI, 15-19) and 42% (95% CI, 23-62); and MCI diagnosis using the MoCA, NIA-AA, MMSE, and Peterson criteria had a prevalence of 64% (95% CI, 59-68), 18% (95% CI, 16-19), 19% (95% CI, 15-23), and 13% (95% CI, 9-17). Meta-regression analysis showed that different MCI diagnostic criteria could be the source of heterogeneity in the pooled results. MCI is common in patients with hypertension, with an overall prevalence of 30%. Earlier cognitive screening and management in hypertensive patients should be advocated.</description><identifier>ISSN: 0916-9636</identifier><identifier>EISSN: 1348-4214</identifier><identifier>DOI: 10.1038/s41440-021-00704-3</identifier><identifier>PMID: 34285378</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Age groups ; Alzheimer Disease ; Cognitive ability ; Cognitive Dysfunction - epidemiology ; Cross-Sectional Studies ; Diuretics ; Epidemiology ; Ethnicity ; Humans ; Hypertension ; Hypertension - complications ; Hypertension - epidemiology ; Medical diagnosis ; Meta-analysis ; Middle Aged ; Prevalence</subject><ispartof>Hypertension research, 2021-10, Vol.44 (10), p.1251-1260</ispartof><rights>2021. The Author(s), under exclusive licence to The Japanese Society of Hypertension.</rights><rights>The Author(s), under exclusive licence to The Japanese Society of Hypertension 2021. corrected publication 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c355t-781b7f3c1d1654278c8b7d59788b502e2072e32bbc9fe564d25db30bd741c8463</citedby><cites>FETCH-LOGICAL-c355t-781b7f3c1d1654278c8b7d59788b502e2072e32bbc9fe564d25db30bd741c8463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34285378$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Qin, Jiawei</creatorcontrib><creatorcontrib>He, Zexiang</creatorcontrib><creatorcontrib>Wu, Lijian</creatorcontrib><creatorcontrib>Wang, Wanting</creatorcontrib><creatorcontrib>Lin, Qiuxiang</creatorcontrib><creatorcontrib>Lin, Yiheng</creatorcontrib><creatorcontrib>Zheng, Liling</creatorcontrib><title>Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis</title><title>Hypertension research</title><addtitle>Hypertens Res</addtitle><description>Mild cognitive impairment (MCI) is common in patients with hypertension. Prevalence estimates of MCI in hypertensive patients are needed to guide both public health and clinical decision making. A literature search was conducted in four databases, including PubMed, Embase, Cochrane Library, and Web of Science, from their inception to February 2021. The methodological quality assessment used the risk of bias tool. The pooled prevalence of MCI in hypertensive patients was determined by a random-effects model. Heterogeneity was explored using sensitivity analysis, subgroup analysis, and random effects meta-regression. Of 2314 references, 11 studies (47,179 participants) were included in the meta-analysis. The overall pooled prevalence of MCI in patients with hypertension was 30% (95% CI, 25-35), with significant heterogeneity present (I
= 99.3%, p < 0.001). In subgroup analyses, Asian and European samples had a prevalence of 26% (95% CI, 20-31) and 40% (95% CI, 14-66), respectively; cross-sectional and cohort studies had a prevalence of 28% (95% CI, 24-32) and 38% (95% CI, -5-81); age older than 60 years had a prevalence of 28% (95% CI, 23-33); community-based and clinic-based samples had a prevalence of 17% (95% CI, 15-19) and 42% (95% CI, 23-62); and MCI diagnosis using the MoCA, NIA-AA, MMSE, and Peterson criteria had a prevalence of 64% (95% CI, 59-68), 18% (95% CI, 16-19), 19% (95% CI, 15-23), and 13% (95% CI, 9-17). Meta-regression analysis showed that different MCI diagnostic criteria could be the source of heterogeneity in the pooled results. MCI is common in patients with hypertension, with an overall prevalence of 30%. Earlier cognitive screening and management in hypertensive patients should be advocated.</description><subject>Age groups</subject><subject>Alzheimer Disease</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - epidemiology</subject><subject>Cross-Sectional Studies</subject><subject>Diuretics</subject><subject>Epidemiology</subject><subject>Ethnicity</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - complications</subject><subject>Hypertension - epidemiology</subject><subject>Medical diagnosis</subject><subject>Meta-analysis</subject><subject>Middle Aged</subject><subject>Prevalence</subject><issn>0916-9636</issn><issn>1348-4214</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkU9P3DAUxK2qqCzbfgEOyBIXLi7-Gzu9VQhKJSQ40LPlOC9do8RJbS9ovz3eLuXQ05vDb0ZPMwidMvqVUWEus2RSUkI5I5RqKon4gFZMSEMkZ_IjWtGWNaRtRHOMTnJ-opQb1bJP6FjIqoQ2KzQ-JHh2I0QPeB7wFMYe-_l3DCU8Aw7T4kKaIBYcIl5cCVVm_BLKBm92C6QCMYc5fsMO510uMFXE4xoZ4AW72OMJiiMuunGXQ_6MjgY3Zvjydtfo183149Utubv_8fPq-x3xQqlCtGGdHoRnPWuU5Np40-letdqYTlEOnGoOgnedbwdQjey56jtBu15L5o1sxBpdHHKXNP_ZQi52CtnDOLoI8zZbrpQwrG00q-j5f-jTvE313z2lTS2Q0j3FD5RPc84JBrukMLm0s4za_Rb2sIWtW9i_W1hRTWdv0dtugv7d8q988Qp6qoUG</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Qin, Jiawei</creator><creator>He, Zexiang</creator><creator>Wu, Lijian</creator><creator>Wang, Wanting</creator><creator>Lin, Qiuxiang</creator><creator>Lin, Yiheng</creator><creator>Zheng, Liling</creator><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20211001</creationdate><title>Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis</title><author>Qin, Jiawei ; He, Zexiang ; Wu, Lijian ; Wang, Wanting ; Lin, Qiuxiang ; Lin, Yiheng ; Zheng, Liling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c355t-781b7f3c1d1654278c8b7d59788b502e2072e32bbc9fe564d25db30bd741c8463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age groups</topic><topic>Alzheimer Disease</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - epidemiology</topic><topic>Cross-Sectional Studies</topic><topic>Diuretics</topic><topic>Epidemiology</topic><topic>Ethnicity</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - complications</topic><topic>Hypertension - epidemiology</topic><topic>Medical diagnosis</topic><topic>Meta-analysis</topic><topic>Middle Aged</topic><topic>Prevalence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qin, Jiawei</creatorcontrib><creatorcontrib>He, Zexiang</creatorcontrib><creatorcontrib>Wu, Lijian</creatorcontrib><creatorcontrib>Wang, Wanting</creatorcontrib><creatorcontrib>Lin, Qiuxiang</creatorcontrib><creatorcontrib>Lin, Yiheng</creatorcontrib><creatorcontrib>Zheng, Liling</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qin, Jiawei</au><au>He, Zexiang</au><au>Wu, Lijian</au><au>Wang, Wanting</au><au>Lin, Qiuxiang</au><au>Lin, Yiheng</au><au>Zheng, Liling</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis</atitle><jtitle>Hypertension research</jtitle><addtitle>Hypertens Res</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>44</volume><issue>10</issue><spage>1251</spage><epage>1260</epage><pages>1251-1260</pages><issn>0916-9636</issn><eissn>1348-4214</eissn><abstract>Mild cognitive impairment (MCI) is common in patients with hypertension. Prevalence estimates of MCI in hypertensive patients are needed to guide both public health and clinical decision making. A literature search was conducted in four databases, including PubMed, Embase, Cochrane Library, and Web of Science, from their inception to February 2021. The methodological quality assessment used the risk of bias tool. The pooled prevalence of MCI in hypertensive patients was determined by a random-effects model. Heterogeneity was explored using sensitivity analysis, subgroup analysis, and random effects meta-regression. Of 2314 references, 11 studies (47,179 participants) were included in the meta-analysis. The overall pooled prevalence of MCI in patients with hypertension was 30% (95% CI, 25-35), with significant heterogeneity present (I
= 99.3%, p < 0.001). In subgroup analyses, Asian and European samples had a prevalence of 26% (95% CI, 20-31) and 40% (95% CI, 14-66), respectively; cross-sectional and cohort studies had a prevalence of 28% (95% CI, 24-32) and 38% (95% CI, -5-81); age older than 60 years had a prevalence of 28% (95% CI, 23-33); community-based and clinic-based samples had a prevalence of 17% (95% CI, 15-19) and 42% (95% CI, 23-62); and MCI diagnosis using the MoCA, NIA-AA, MMSE, and Peterson criteria had a prevalence of 64% (95% CI, 59-68), 18% (95% CI, 16-19), 19% (95% CI, 15-23), and 13% (95% CI, 9-17). Meta-regression analysis showed that different MCI diagnostic criteria could be the source of heterogeneity in the pooled results. MCI is common in patients with hypertension, with an overall prevalence of 30%. Earlier cognitive screening and management in hypertensive patients should be advocated.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>34285378</pmid><doi>10.1038/s41440-021-00704-3</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0916-9636 |
| ispartof | Hypertension research, 2021-10, Vol.44 (10), p.1251-1260 |
| issn | 0916-9636 1348-4214 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2553819671 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Age groups Alzheimer Disease Cognitive ability Cognitive Dysfunction - epidemiology Cross-Sectional Studies Diuretics Epidemiology Ethnicity Humans Hypertension Hypertension - complications Hypertension - epidemiology Medical diagnosis Meta-analysis Middle Aged Prevalence |
| title | Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T08%3A32%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20mild%20cognitive%20impairment%20in%20patients%20with%20hypertension:%20a%20systematic%20review%20and%20meta-analysis&rft.jtitle=Hypertension%20research&rft.au=Qin,%20Jiawei&rft.date=2021-10-01&rft.volume=44&rft.issue=10&rft.spage=1251&rft.epage=1260&rft.pages=1251-1260&rft.issn=0916-9636&rft.eissn=1348-4214&rft_id=info:doi/10.1038/s41440-021-00704-3&rft_dat=%3Cproquest_cross%3E2553819671%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2578916001&rft_id=info:pmid/34285378&rfr_iscdi=true |